Ferric Carboxymaltose Therapy Does Not Significantly Improve Heart Failure Mortality
August 31st 2023Ferric carboxymaltose was not found to have a significant impact on 6-minute walk distance, which is part of the primary outcome’s hierarchical composite of death and hospitalizations from heart failure.